Malignant Glioma

Development of chimeric antigen receptor (CAR) T-cell immunotherapy for glioblastoma targeting epidermal growth factor receptor variant III (EGFRvIII)
Anthony K Park, Saul Priceman, Ethan Gerdts, Wen-Chung Chang, Sarah Wright, Stephen J Forman, Christine E Brown

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P119; DOI: 10.1186/2051-1426-3-S2-P119
Targeted multi-epitope therapeutic vaccine for the treatment of invasive glioblastoma multiforme
Xiaofang Huang, Rashida Ginwala, Aykan Karabudak, Pooja Jain, Ramila Philip

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P436; DOI: 10.1186/2051-1426-3-S2-P436
Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
Yafei Hou, Gary Kohanbash, Kaori Okada, Shruti Shrivastav, Matthew Smith-Cohn, Theodore Nicolaides, Sabine Mueller, Angel Carcaboso, Ian Pollack, Hideho Okada

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P445; DOI: 10.1186/2051-1426-3-S2-P445
Functional IL-17R in glioma stem cells: potential role in tumor progression and therapeutic implications
Prahlad Parajuli, Rohit Anand, Chandramouli Mandalaparty, Raviteja Suryadevara, Preethi Sriranga, Sharon Michelhaugh, Archana Thakur, Lawrence G Lum, Chaya Brodie, Sandeep Mittal

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P412; DOI: 10.1186/2051-1426-3-S2-P412
Adjuvant inhibition of iAPC function in the tumor microenvironment promotes therapeutic immunity in the setting of vaccination-induced T cell anti-tumor response
Joseph Antonios, Horacio Soto, Joey Orpilla, Namjo Shin, Richard Everson, Linda Liau, Robert Prins

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P393; DOI: 10.1186/2051-1426-3-S2-P393

Log in using your username and password

Main menu

Log in using your username and password

You are here

Malignant Glioma